[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364699-105":59,"doc-detail-364699-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","exploring-metabolic-shifts-in-kidney-cancer-and-non-cancer-cells-under-pro-and-anti-apoptotic-treatments-using-nmr-metabolomics","Exploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro-and Anti-Apoptotic Treatments Using NMR Metabolomics","","This study investigates how cancerous (RCC) and non-cancerous (HK2) kidney cells respond metabolically to Staurosporine (STAU), a pro-apoptotic agent, and Bongkrekic acid (BKA), an anti-apoptotic agent, alone and in combination, using 1H NMR metabolomics. STAU causes pronounced metabolic reprogramming in RCC cells, impairing energy production, redox balance, and biosynthesis, consistent with activation of apoptotic pathways. BKA shows minimal metabolic effects in RCC, primarily preserving mitochondrial function, while combined treatment largely reflects STAU effects. HK2 cells exhibit smaller alterations and maintain a more regulated state, supporting cancer-specific metabolic vulnerability targeting and emphasizing metabolomics-based insight into apoptotic and anti-apoptotic mechanisms. Future work should validate findings in vivo and assess personalized treatment strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-metabolic-shifts-in-kidney-cancer-and-non-cancer-cells-under-pro-and-anti-apoptotic-treatments-using-nmr-metabolomics/364699/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-metabolic-shifts-in-kidney-cancer-and-non-cancer-cells-under-pro-and-anti-apoptotic-treatments-using-nmr-metabolomics/364699.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What treatments are compared in the study, and what are their roles?","Question",{"text":113,"@type":114},"The study compares Staurosporine (STAU) as a pro-apoptotic treatment and Bongkrekic acid (BKA) as an anti-apoptotic treatment, both individually and in combination, to examine their effects on kidney cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do RCC and HK2 cells differ in their metabolic responses?",{"text":118,"@type":114},"RCC cells show substantial metabolic reprogramming after STAU, while HK2 non-cancerous cells display far less pronounced metabolic alterations, maintaining a more regulated metabolic state.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the main mechanistic interpretation of the STAU and BKA effects?",{"text":122,"@type":114},"STAU disrupts energy production, redox balance, and biosynthesis, aligning with mitochondrial apoptotic pathway activation, whereas BKA shows minimal metabolic effects in RCC and preserves mitochondrial function, limiting its ability to counteract STAU’s pro-apoptotic impact.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364699,1790248949,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nExploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro-and Anti-Apoptotic Treatments Using NMR Metabolomics  \nLucia Trisolini 1,†, Biagia Musio 2,†, Beatriz Teixeira 3, Maria Noemi Sgobba 1, Anna Lucia Francavilla 1, Mariateresa Volpicella 1, Lorenzo Guerra 1, Anna De Grassi 1, Vito Gallo 2,4, Iola F. Duarte 3, * and Ciro Leonardo Pierri 5, *  \nAcademic Editor: Paolo Bernardi  \nReceived: 22 January 2025  \nRevised: 24 February 2025  \nAccepted: 26 February 2025  \nPublished: 2 March 2025  \nCitation: Trisolini, L.; Musio, B.; Teixeira, B.; Sgobba, M.N.; Francavilla, A.L.; Volpicella, M.; Guerra, L.; De Grassi, A.; Gallo, V.; Duarte, I.F.; et al. Exploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro-and Anti-Apoptotic Treatments Using NMR Metabolomics. Cells 2025, 14, 367. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells14050367  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Biosciences, Biotechnologies and Environment, University of Bari “Aldo Moro”, Via Orabona,  \n4, 70125 Bari, Italy; [lucia.trisolini@uniba.it](lucia.trisolini@uniba.it) (L.T.); [maria.sgobba@uniba.it](maria.sgobba@uniba.it) (M.N.S.);  \n[anna.francavilla@uniba.it](anna.francavilla@uniba.it) (A.L.F.); [mariateresa.volpicella@uniba.it](mariateresa.volpicella@uniba.it) (M.V.); [lorenzo.guerra1@uniba.it](lorenzo.guerra1@uniba.it) (L.G.);  \n[anna.degrassi@uniba.it](anna.degrassi@uniba.it) (A.D.G.)  \n2 Department of Civil, Environmental, Land, Building Engineering and Chemistry (DICATECh), Polytechnic University of Bari, Via Orabona, 4, 70125 Bari, Italy; [biagia.musio@poliba.it](biagia.musio@poliba.it) (B.M.); [vito.gallo@poliba.it](vito.gallo@poliba.it) (V.G.)  \n3 CICECO-Aveiro Institute of Materials and LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal; [b.teixeira@ua.pt](b.teixeira@ua.pt)  \n4 Innovative Solutions S.r.l.—Spin-Off Company of the Polytechnic University of Bari, Zona H 150/B,  \n70015 Noci, Italy  \n5 Department of Pharmacy—Pharmaceutical Sciences, University of Bari “Aldo Moro”, Via Orabona, 4,  \n70125 Bari, Italy  \n* Correspondence: [ioladuarte@ua.pt](ioladuarte@ua.pt) (I.F.D.); [ciro.pierri@uniba.it](ciro.pierri@uniba.it) (C.L.P.)† These authors contributed equally to this work.  \nAbstract: This study investigates the metabolic responses of cancerous (RCC) and noncancerous (HK2) kidney cells to treatment with Staurosporine (STAU), which has a proapoptotic effect, and Bongkrekic acid (BKA), which has an anti-apoptotic effect, individually and in combination, using 1H NMR metabolomics to identify metabolite markers linked to mitochondrial apoptotic pathways. BKA had minimal metabolic effects in RCC cells, suggesting its role in preserving mitochondrial function without significantly altering metabolic pathways. In contrast, STAU induced substantial metabolic reprogramming in RCC cells, disrupting energy production, redox balance, and biosynthesis, thereby triggering apoptotic pathways. The combined treatment of BKA and STAU primarily mirrored the effects of STAU alone, with BKA showing little capacity to counteract the pro-apoptotic effects. In non-cancerous HK2 cells, the metabolic alterations were far less pronounced, highlighting key differences in the metabolic responses of cancerous and non-cancerous cells. RCC cells displayed greater metabolic flexibility, while HK2 cells maintained a more regulated metabolic state. These findings emphasize the potential for targeting cancer-specific metabolic vulnerabilities while sparing non-cancerous cells, underscoring the value of metabolomics in understanding apoptotic and anti-a","cbCaim79pX7VUZ0s","https://ap.wps.com/l/cbCaim79pX7VUZ0s","pdf",5085169,18,"English","# Introduction\n## Kidney cancer and therapeutic challenges\n## Metabolic profiling in cancer\n## Apoptosis and mitochondrial pathways\n## Pro-apoptotic action of Staurosporine\n## Anti-apoptotic action of Bongkrekic acid","[{\"question\":\"What treatments are compared in the study, and what are their roles?\",\"answer\":\"The study compares Staurosporine (STAU) as a pro-apoptotic treatment and Bongkrekic acid (BKA) as an anti-apoptotic treatment, both individually and in combination, to examine their effects on kidney cells.\"},{\"question\":\"How do RCC and HK2 cells differ in their metabolic responses?\",\"answer\":\"RCC cells show substantial metabolic reprogramming after STAU, while HK2 non-cancerous cells display far less pronounced metabolic alterations, maintaining a more regulated metabolic state.\"},{\"question\":\"What is the main mechanistic interpretation of the STAU and BKA effects?\",\"answer\":\"STAU disrupts energy production, redox balance, and biosynthesis, aligning with mitochondrial apoptotic pathway activation, whereas BKA shows minimal metabolic effects in RCC and preserves mitochondrial function, limiting its ability to counteract STAU’s pro-apoptotic impact.\"}]","Exploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro-and Anti-Apoptotic Treatments Using NMR Metabolomics | PDF",1790158782,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b5e255b2a1ff5df784b010491fdf89a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26b5d62a362cbc678f960120e68ed7bc.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c60778caaa7a2479a47515af1d566bf.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a842e4e2598e166de2afc074c5233a5c.webp",980,1385]